Recall Record

Montbonnot-Saint-Martin, N/A, France

Tornier S.A.S. recalls

5 recalls recorded since 2018, most recently on 10 April 2025. 5 are listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)5
Terminated or completed0
Class I (FDA)0

Ongoing Class II Medical devices

Recall started
10 April 2025
Reason
A software bug in Blueprint version 4.2.1 prevents users from accessing cases initiated in previous versions of the software.
Distribution
Blueprint Version 4.2.1 is only currently available in the US. Domestic distribution nationwide.
Initiated
Voluntary: Firm initiated
Recall number
Z-1738-2025

Ongoing Class II Medical devices

Recall started
5 March 2025
Reason
Stryker identified an elevated complaint rate related to difficulties using the Blueprint Mixed Reality Guidance Instrumentation system is multifactorial, but in each instance prohibits the system from meeting its intended use. The most commonly reported complaints were related to impaired software functioning, impaired instrumentation functioning, and general difficulties using the product.
Distribution
US: TX, MN, AK, PA, MA, TN, ID, and France, Canada, and Ireland
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1536-2025, Z-1535-2025, Z-1540-2025, Z-1541-2025, Z-1538-2025, Z-1534-2025, Z-1537-2025, Z-1542-2025, Z-1539-2025

Ongoing Class II Medical devices

Recall started
18 December 2024
Reason
The Pin Guide is being recalled because the metal tube may disassemble from the plastic handle. This can result in the Blueprint Mixed Reality headset being unable to detect the Pin Guide and potentially prolonging surgery time or changing of surgical method from guided to conventional.
Distribution
US: MN, KY, MD, MA, TX, AK, TX, ID; France, Canada
Initiated
Voluntary: Firm initiated
Recall number
Z-0846-2025

Ongoing Class II Medical devices

Recall started
16 April 2024
Reason
The software bug allows for case planning with anatomic glenoid Perform / Perform Augmented implants and anatomic humeral Tornier Flex implant configurations that are incompatible and do not have regulatory approval.
Distribution
US Nationwide distribution in the states of FL, KY, NJ, and WI.
Initiated
Voluntary: Firm initiated
Recall number
Z-1883-2024

Ongoing Class II Medical devices

Recall started
25 June 2021
Reason
Potential patient exposure to the graphite substrate.
Distribution
CA, CO, CT, FL, KS, LA, MD, MI, MN, MO, NC, OR, PA, TX and WI
Initiated
Voluntary: Firm initiated
Recall number
Z-2291-2021

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.